These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1409441)

  • 21. The mahogany mouse mutation: further links between pigmentation, obesity and the immune system.
    Jackson IJ
    Trends Genet; 1999 Nov; 15(11):429-31. PubMed ID: 10529800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology and genetics of oculocutaneous albinism and vitiligo - common pigmentation disorders in southern Africa.
    Manga P; Kerr R; Ramsay M; Kromberg JG
    S Afr Med J; 2013 Jul; 103(12 Suppl 1):984-8. PubMed ID: 24300644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable expression of vision in sibs with albinism.
    Summers CG; Creel D; Townsend D; King RA
    Am J Med Genet; 1991 Sep; 40(3):327-31. PubMed ID: 1951438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB; Spritz RA
    Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract]   [Full Text] [Related]  

  • 26. Computational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence.
    Hassan M; Abbas Q; Raza H; Moustafa AA; Seo SY
    Mol Biosyst; 2017 Jul; 13(8):1534-1544. PubMed ID: 28640309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory factors of pheo- and eumelanogenesis in melanogenic compartments.
    Jimbow K; Alena F; Dixon W; Hara H
    Pigment Cell Res; 1992; Suppl 2():36-42. PubMed ID: 1409437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human pigmentation genetics: the difference is only skin deep.
    Sturm RA; Box NF; Ramsay M
    Bioessays; 1998 Sep; 20(9):712-21. PubMed ID: 9819560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of mouse Himalayan mutation.
    Kwon BS; Halaban R; Chintamaneni C
    Biochem Biophys Res Commun; 1989 May; 161(1):252-60. PubMed ID: 2567165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progresses in understanding pigmentation.
    Kosmadaki MG; Naif A; Hee-Young P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):47-55. PubMed ID: 20197745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair melanins and hair color: ultrastructural and biochemical aspects.
    Ortonne JP; Prota G
    J Invest Dermatol; 1993 Jul; 101(1 Suppl):82S-89S. PubMed ID: 8326157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A splicing mutation of the tyrosinase gene causes yellow oculocutaneous albinism in a Japanese patient with a pigmented phenotype.
    Matsunaga J; Dakeishi-Hara M; Tanita M; Nindl M; Nagata Y; Nakamura E; Miyamura Y; Kikuchi K; Furue M; Tomita Y
    Dermatology; 1999; 199(2):124-9. PubMed ID: 10559577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome.
    Garrison NA; Yi Z; Cohen-Barak O; Huizing M; Hartnell LM; Gahl WA; Brilliant MH
    J Med Genet; 2004 Jun; 41(6):e86. PubMed ID: 15173252
    [No Abstract]   [Full Text] [Related]  

  • 35. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism.
    Giménez E; Lavado A; Giraldo P; Cozar P; Jeffery G; Montoliu L
    Pigment Cell Res; 2004 Aug; 17(4):363-70. PubMed ID: 15250938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversion mutation of ib oculocutaneous albinism to wild-type pigmentation in medaka fish.
    Iida A; Takamatsu N; Hori H; Wakamatsu Y; Shimada A; Shima A; Koga A
    Pigment Cell Res; 2005 Oct; 18(5):382-4. PubMed ID: 16162178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Hypomorphic Alleles of the Mouse Tyrosinase Gene Induced by CRISPR-Cas9 Nucleases Cause Non-Albino Pigmentation Phenotypes.
    Challa AK; Boitet ER; Turner AN; Johnson LW; Kennedy D; Downs ER; Hymel KM; Gross AK; Kesterson RA
    PLoS One; 2016; 11(5):e0155812. PubMed ID: 27224051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel pink-eyed dilution mouse model showing progressive darkening of the eyes and coat hair with aging.
    Ishikawa A; Sugiyama M; Hondo E; Kinoshita K; Yamagishi Y
    Exp Anim; 2015; 64(2):207-20. PubMed ID: 25739360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hair pigmentation in transgenic mice.
    Tanaka S; Takeuchi T
    Ann N Y Acad Sci; 1991 Dec; 642():407-18. PubMed ID: 1809095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.